Eagle Asset Management Inc Puma Biotechnology, Inc. Transaction History

Eagle Asset Management Inc

  • $16.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 08, 2018
SELL
$41.2 - $59.85 $9.79 Million - $14.2 Million
-237,710 Closed
0 $0
Q2 2018

Aug 07, 2018
SELL
$48.3 - $68.25 $2.97 Million - $4.2 Million
-61,533 Reduced 20.56%
237,710 $14.1 Million
Q1 2018

May 09, 2018
BUY
$59.7 - $99.25 $96,893 - $161,082
1,623 Added 0.55%
299,243 $20.4 Million
Q4 2017

Feb 09, 2018
BUY
$93.85 - $132.45 $27.9 Million - $39.4 Million
297,620
297,620 $28.9 Million

Others Institutions Holding PBYI

# of Institutions
101
Shares Held
29M
Call Options Held
50.6K
Put Options Held
16.3K
View Full List

About PUMA BIOTECHNOLOGY, INC.

PBYI Quotes by TradingView
  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $151M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track Eagle Asset Management Inc Portfolio

Follow Eagle Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email